Skip to main content
ZYME logo

ZYME · Zymeworks Inc. · Share Buybacks

Track ZYME — free
$26.00 -0.04 (-0.15%) Play latest call Q1 2026 earnings call transcript
Market Cap
$1.80B
Shares
69.03M
Volume · Nov 18 1.09M Avg daily vol (3M) 1.08M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$200,000,000
as of 2026-11-16 · from Press release (reviewed)
Program Announced Authorized Remaining Runs Through
2026-11-16 $200,000,000 — —
2026-05-14 $125,000,000 $89,600,000 —
2025-11-18 $125,000,000 — —

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-09-30 YTD $140,092,000
2025-12-31 $41,695,000
2024-12-31 $30,051,000
Key facts CIK 1937653 CUSIP 98985Y108 13F (30d) 206 filings 192 filers Visit website Investor relations